WO2025202204 - PROBIOTIC BIFIDOBACTERIUM BREVE FOR USE IN PREVENTION OF EXTRA-INTESTINAL SYMPTOMS OF INTESTINAL BOWEL SYNDROME
National phase entry is expected:
Publication Number
WO/2025/202204
Publication Date
02.10.2025
International Application No.
PCT/EP2025/058144
International Filing Date
25.03.2025
Title **
[English]
PROBIOTIC BIFIDOBACTERIUM BREVE FOR USE IN PREVENTION OF EXTRA-INTESTINAL SYMPTOMS OF INTESTINAL BOWEL SYNDROME
[French]
BIFIDOBACTERIUM BREVE PROBIOTIQUE DESTINÉ À ÊTRE UTILISÉ DANS LA PRÉVENTION DE SYMPTÔMES EXTRA-INTESTINAUX DU SYNDROME DE L'INTESTIN IRRITABLE
Applicants **
CHR. HANSEN A/S
Inventors
HALKJAER, Sofie Ingdam
PETERSEN, Andreas Munk
GROENBAEK, Ida Marie Bruun
ENGEL, Sara
DAMHOLT, Anders
Priority Data
24165995.2
25.03.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1994 | |
| EPO | Filing, Examination, Granting | 8141 | |
| Japan | Filing, Examination, Granting | 2138 | |
| South Korea | Filing, Examination, Granting | 1997 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
19,610
Contact Us
Abstract[English]
or Bifidobacterium breve strain deposited as DSM 32356 or compositions comprising said bacteria for use in preventing, reducing, or ameliorating fatigue symptoms of Intestinal Bowel Syndrome, in particular diarrhea predominant Intestinal Bowel Syndrome.[French]
ou la souche de Bifidobacterium breve déposée sous DSM 32356 ou des compositions comprenant lesdites bactéries destinés à être utilisées dans la prévention, la réduction ou l'amélioration des symptômes de fatigue associés au syndrome de l'intestin irritable, en particulier le syndrome de l'intestin irritable à diarrhée prédominante.